BRILINTA can lead to fewer CV events for STEMI patients compared to clopidogrel, allowing a growing support for BRILINTA® (ticagrelor) [package insert]. Find out about the BRILINTA® (ticagrelor) mechanism of action. BRILINTA is the first-and-only ;(3) BRILINTA® (ticagrelor) [package insert]. Patient Information Leaflet. Package leaflet: Information for the user. Brilique 90 mg film-coated tablets ticagrelor. Read all of this leaflet carefully before you start .
|Published (Last):||2 December 2015|
|PDF File Size:||5.79 Mb|
|ePub File Size:||2.39 Mb|
|Price:||Free* [*Free Regsitration Required]|
You may report side effects related to AstraZeneca products by clicking here.
The optimal duration of Plavix therapy is unknown. Strong inducers substantially reduce ticagrelor exposure and so decrease the efficacy of ticagrelor As with other oral P2Y 12 inserf, co-administration of opioid agonists delay and reduce the absorption of ticagrelor.
BRILINTA is used with aspirin to lower packwge chance of having another serious problem with your heart or blood vessels such as heart attack, stroke, or blood clots in your stent if you received one. Plavix should be administered in conjunction with aspirin.
A CHANGING TREATMENT PARADIGM
Tell your doctor if you take other medicines that contain aspirin. Administer 90 mg twice daily during the first year after an ACS event.
For complete information on changes to the Plavix PI, go to www. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. People who are treated with a stent, and stop taking BRILINTA too soon, have a higher risk of getting a blood clot in the stent, having a heart attack, or dying.
Plavix is a registered trademark of sanofi-aventis. Your doctor can decide what treatment is needed. You may report side effects related to AstraZeneca products by clicking here.
Evolving Treatment Paradigm in ACS | BRILINTA® (ticagrelor) tablets
Subject to eligibility rules ; restrictions apply. Plavix is indicated to inswrt the rate of myocardial infarction and stroke For in patients with acute ST-elevation myocardial infarction STEMI who are to be managed medically. Bleeding will also take longer than usual to stop.
For at least the first 12 months following ACS, it is superior to clopidogrel. Do not take new medicines that contain aspirin. These can be fatal.
BRILINTA® (ticagrelor) tablets | Antiplatelet & Heart Attack Treatment
Call your doctor if you have new or unexpected shortness of breath or any side effect that bothers you or that does not brilintz away. Plavix has been shown to decrease the rate of a combined endpoint of cardiovascular death, myocardial infarction MIor stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia.
I recently had a heart attack, but I am not insery victim.
Strong inhibitors substantially increase ticagrelor exposure brilunta so increase the risk of adverse events. The benefit for patients who undergo primary percutaneous coronary intervention is unknown.
BRILINTA MECHANISM OF ACTION
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Plavix has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re infarction, or stroke. Bradyarrhythmias including AV block have been reported in the post-marketing setting.
After one year administer 60 mg twice daily.